Prostate Biomarkers in Men Consuming Tomato Products
NCT02292524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2014-11-17
Summary
Prostate Biomarkers in Men Consuming Tomato Products
Conditions
Interventions
- OTHER
-
Commercially-available tomato food product
Each of the three tomato food products (juice, soup, sauce) provided 25-35 mg lycopene/day.
Sponsors & Collaborators
-
Schwartz, Steven, PhD
collaborator UNKNOWN -
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Steven Clinton, MD · The Ohio State University Comprehensive Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-05-31
- Primary Completion
- 2004-10-31
- Completion
- 2004-10-31
Countries
- United States
Study Locations
More Related Trials
-
Saw Palmetto: Symptom Management for Men During Radiation Therapy
NCT01585246 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Early Staged Consent Before Prostate Biopsy
NCT03507725 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
NCT00373035 ·Status: COMPLETED
-
Infective Complications in TP Biopsy Without Antibiotic Prophylaxis
NCT06359964 ·Status: RECRUITING ·Phase: NA
-
FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer
NCT00917865 ·Status: TERMINATED ·Phase: PHASE2
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT06200259 ·Status: RECRUITING ·Phase: NA
-
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT06172283 ·Status: RECRUITING ·Phase: NA
-
An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT00997464 ·Status: UNKNOWN
-
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
NCT02722525 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
NCT01365182 ·Status: COMPLETED ·Phase: NA
-
Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors
NCT03459755 ·Status: WITHDRAWN ·Phase: NA
-
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
NCT06159998 ·Status: WITHDRAWN
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Focal Therapy for Prostate Cancer
NCT01802307 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Cleveland African American Prostate Cancer Project
NCT05469269 ·Status: RECRUITING ·Phase: NA
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING
-
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery
NCT01766492 ·Status: UNKNOWN
-
Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer
NCT02375035 ·Status: UNKNOWN
-
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
NCT02997709 ·Status: RECRUITING
-
Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer
NCT05318131 ·Status: COMPLETED ·Phase: NA
-
Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors
NCT02704377 ·Status: COMPLETED ·Phase: NA
-
Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
NCT02501759 ·Status: TERMINATED ·Phase: NA
-
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics
NCT03237702 ·Status: RECRUITING ·Phase: NA